MYC and breast carcinoma: Our results indicated that several compounds, including c‐Myc‐i7, c‐Myc‐i8, and c‐Myc‐i10, exhibited remarkable reductions in cell viability across various cancer types, including lung, pancreatic, prostate, and breast cancers.